| ABCG2 | ATP-binding cassette super-family G member 2 |
| AC | Adenocarcinoma |
| AD | Adenoma |
| AKT | Serine/threonine kinase Akt, or protein kinase B (PKB) |
| ALDH1 | Aldehyde dehydrogenase 1 |
| APC | Adenomatous polyposis coli |
| BMPR1A | Bone morphogenetic protein receptor, type 1A |
| BRAF | Protooncogene B-Raf; encodes protein called B-Raf |
| Brd/Id/Urd | Bromo-, iodo-deoxyuridine |
| CAMs | Cell adhesion molecules |
| CCND2 | G1/S-specific cyclin-D2 |
| CD44 | CD44 molecule (Indian blood group), a cell-surface glycoprotein |
| Cdks | Cyclin-dependent kinases |
| CEA | Carcinoembryonic antigen |
| CCS | Colon cancer subtype |
| CI | Confidence interval |
| CIMP | CpG island methylator phenotype |
| CIN | Chromosomal instability |
| CMS | Consensus molecular subtype |
| CRC | Colorectal cancer |
| CRLM(s) | Colorectal cancer liver metastasis(es) |
| CSCs | Cancer stem cells |
| CSS | Cancer-specific survival |
| DCC | Deleted in colorectal cancer |
| DFS | Disease-free survival |
| EdU | 5-Ethynyl-2′-deoxyuridine |
| EGFR | Epidermal Growth Factor Receptor (HER1 in humans) |
| EIF3H | Eukaryotic translation initiation factor 3 subunit H |
| EMT | Epithelial-mesenchymal transition |
| ERK | Extracellular signal-regulated kinase or classical MAP kinase (MAPK) |
| FAP | Familial adenomatous polyposis |
| FCM | Flow cytometry |
| FDG | 18-Fluoro-2-deoxy-D-glucose |
| FLT | 18-Fluoro-3-deoxy-3-fluorothymidine |
| GALT | Gut-associated lymphoid tissue |
| GI | Gastrointestinal |
| GLUT1 | Glucose transporter 1 |
| GREM1 | Gremlin 1, DAN family BMP antagonist |
| HIF-1 | Hypoxia-inducible factor 1 |
| HNPCC | Hereditary non-polyposis colorectal cancer |
| HPs | Hyperplastic polyps |
| HPFs | High-power fields |
| HR | Hazard ratio |
| IGF-2 | Insulin growth factor 2 |
| IGFBP2 | IGF binding protein 2 |
| IHC | Immunohistochemistry |
| ISCs | Intestinal stem cells |
| ISH | In situ hybridization |
| JAK | Janus kinase |
| JNK | c-Jun N-terminal kinase |
| KRAS/K-ras | Kirsten rat sarcoma virus; encodes protein called K-Ras |
| LGR5 | G-protein-coupled receptor 5 |
| LKB1 | Serine/threonine-protein kinase STK11 |
| LI | Labeling index |
| LS | Lynch syndrome |
| mAb(s) | Monoclonal antibody (antibodies) |
| MAPK | Mitogen-activated protein kinase |
| MCC | Colorectal mutant cancer protein |
| MKI67 | Marker of proliferation Ki-67 gene |
| MLH1, 2, 6 | MutL homolog 1, 2, 6 |
| MMR | DNA mismatch repair |
| MSI-H | High microsatellite instability |
| MSH2 | MutS homolog 2 |
| MSS | Microsatellite stable |
| MUTYH | E. coli MutY homolog |
| NCAMs | Neural cell adhesion molecules |
| OS | Overall survival |
| PCNA | Proliferating cell nuclear antigen |
| PFS | Progression-free survival |
| PI | Proliferating index |
| PI3K | Phosphatidylinositol-3-kinase |
| PKM2 | Pyruvate kinase M2 |
| PMS2 | Mismatch repair endonuclease 2 |
| PP1 | Protein phosphatase 1 |
| PTEN | Phosphatase and tensin homolog deleted on chromosome ten |
| RAS | Oncogene “Rat sarcoma virus” from three Ras genes: HRAS, KRAS and NRAS |
| RC | Rectal cancer |
| RFS | Relapse/recurrence-free survival |
| RT | Radiotherapy |
| RT-PCR/qRT-PCR | Reverse transcriptase-polymerase chain reaction; quantitative real-time PCR |
| SMAD4 | SMAD family member 4, Mothers Against DPP Homolog 4 |
| SOX2 | Transcription factor 2, known also as sex determining region Y (SRY)-box 2 |
| SPs | Serrated polyps |
| SPS | Serrated polyposis syndrome |
| SSLs | Sessile serrated lesions |
| STAT3 | Signal transducer and activator of transcription 3 |
| TCGA | The cancer genome atlas |
| TGF-β | Transforming growth factor beta |
| TMA | Tissue microarray |
| TME | Tumor microenvironment |
| TNM | Tumor-node-metastasis |
| TP53/p53 | Tumor gene/protein 53 |
| Tpot | The potential tumor doubling time |
| Ts | Duration of S phase |
| TS | Thymidylate synthase |
| VEGF | Vascular endothelial growth factor |
| Wnt/WNT | Gene wingless + integrated or int-1 |